Category / Quality Control / Uncategorized
-
![]()
From Sample Integrity to Analyser Confidence
Haemolysis, Icterus and Lipaemia (HIL) Following a series of expert-led HIL sessions at ADLM 2026, we recap the key insights shared on haemolysis, icterus and lipaemia, exploring their impact… -
![]()
Randox Health Launches ‘RanChip Insight 360’ – A New Era in Preventative Health Intelligence
London, United Kingdom – 4th June 2026 Randox Health today announces the launch of RanChip Insight 360, an advanced health intelligence programme designed to transform how individuals understand, monitor,… -
![]()
The PHIND Study – Identifying inflammatory subphenotypes in a real-world clinical setting
Retrospective analyses have identified two biologically distinct subphenotypes (hyperinflammatory and hypoinflammatory) of acute respiratory distress syndrome (ARDS), with differing outcomes and responses to therapy. Rapid identification of these subphenotypes in… -
![]()
2026 Guideline on the Management of Dyslipidemia
The American College of Cardiology and American Heart Association joint committee have published a report on Clinical Practice Guidelines relating to the management of Dyslipidemia. The report introduces important updates… -
![]()
Grand National legends Ruby Walsh and Danny Mullins set the tone for the Randox Grand National 10 Year Sponsorship Celebration
County Antrim, Northern Ireland Celebrating 10 years of proud sponsorship of the Randox Grand National, Ruby Walsh and Danny Mullins took centre stage at Randox Head Quarters to highlight… -
![]()
The 2026 Randox Grand National Trophy: A Decade of Partnership, A Legacy of Excellence
The Randox Grand National is more than a race - it is a defining test of endurance, precision and courage, watched by millions across the world. As Randox proudly marks… -
![]()
Public Health Response Strengthened with Rapid Forensic Toxicology
A new forensic toxicology testing analyser has been introduced by the Government of the Northwest Territories (GNWT) in a bid to combat the illicit drug contamination and toxicity crisis. Across… -
![]()
Ensuring Reliable HIL Detection: Why Quality Control Matters for Patient Safety
The Impact of HIL on Sample Integrity Haemolysis (H), icterus (I) and lipemia (L) (HIL) are among the most common pre-analytical interferences in clinical chemistry testing. They can significantly affect… -
![]()
MD One Ventures & Randox launch Accelerator Randox for Builders
MD One Ventures, Europe's first Defence and National Security Venture Capital team and Randox, a global diagnostics and healthcare company from the UK and Ireland, today announce the launch of… -
![]()
Third Party Controls and their Benefits
Third party controls have been designed to deliver an independent, unbiased assessment of performance with any instrument or method helping you gain accreditation.
Loading posts...
